With a platelet count of 86 × 10³/µL, what phase of dengue is the patient in?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Dengue Phase with Platelet Count of 86 × 10³/µL

With a platelet count of 86 × 10³/µL, the patient is most likely in the late febrile phase transitioning into the critical phase of dengue infection.

Clinical Context and Timing

The platelet count of 86 × 10³/µL falls below the threshold of 100 × 10³/µL, which is a defining laboratory criterion for dengue hemorrhagic fever according to CDC guidelines 1. This thrombocytopenia typically develops during days 3-7 of illness, marking the transition from febrile to critical phase.

The critical phase typically begins around day 5 of fever onset, when platelet counts drop most dramatically 2, 3. Studies show that maximal thrombocytopenia occurs between the 5th and 8th day from onset of constitutional symptoms 3.

Phase Classification Based on Platelet Count

The platelet count of 86 × 10³/µL provides important prognostic information:

  • Dengue fever without warning signs: median platelet count 114,000/µL 4
  • Dengue with warning signs: median platelet count 35,500/µL 4
  • Severe dengue: median platelet count 25,000/µL 4

Your patient's count of 86 × 10³/µL suggests dengue fever approaching the critical phase, but not yet meeting criteria for dengue with warning signs based on platelet count alone.

Critical Monitoring Requirements

You must monitor for plasma leakage indicators over the next 24-48 hours, as this platelet level signals impending critical phase:

  • Hematocrit changes: An increase ≥5% compared to previous day concurrent with platelet drop ≥50% predicts dengue shock syndrome with 86.6% sensitivity 5
  • Clinical warning signs: Abdominal pain, persistent vomiting, mucosal bleeding, lethargy, hepatomegaly, fluid accumulation
  • Plasma leakage evidence: Hemoconcentration (hematocrit increased ≥20%) or objective evidence of increased capillary permeability 1

Bleeding Risk Assessment

The bleeding risk at this platelet level is moderate but increases substantially if counts continue dropping. Patients with platelet counts <25,000/µL have 7.5 times higher odds of developing severe dengue 4. The hyperdestructive thrombocytopenia phenotype (high immature platelet fraction) carries the highest bleeding frequency at 57.1% 6.

Common Pitfalls to Avoid

  • Do not rely on platelet count alone - disease severity, not just platelet phenotype, is the strongest predictor of bleeding (OR 41.83) 6
  • Do not miss the critical phase window - nearly half of patients are admitted on day 5, risking delayed identification of plasma leakage 2
  • Monitor daily hematocrit and platelet trends - the kinetics of change are more predictive than absolute values 5
  • Leukopenia accompanies thrombocytopenia - over 70% have lowest white cell counts between days 5-8 3

References

3
Research

Dengue fever with thrombocytopenia: studies towards defining vulnerability of bleeding.

Boletin de la Asociacion Medica de Puerto Rico, 1995

Related Questions

In a day‑6 dengue patient who is afebrile with a platelet count of 6 × 10⁹/L, is a rise in hematocrit from 45 % to 47 % clinically significant?
In a patient with 4 days of fever, hypotension, tachycardia, sweating, and uneasiness, whose platelet count fell from 35 × 10⁹/L to 25 × 10⁹/L within 6 hours, what is the recommended management?
In a patient with dengue fever and severe thrombocytopenia, what investigations and severity scores should be performed?
What CBC findings are typical in dengue, and how frequently should the CBC be repeated to monitor the critical phase?
What platelet count threshold should be targeted in a pregnant woman with dengue infection for safe delivery?
In acute pancreatitis, should a gelatin‑based colloid be administered as a 500–1000 mL bolus when the patient shows signs of hypovolemia?
In a dengue patient presenting with pulmonary congestion, could this indicate heart failure and what is the appropriate management?
Is sciatica the same condition as radiculopathy?
What is the appropriate empirical treatment for a 2‑day‑old penile ulcer?
What is the epidemiology, including prevalence and risk factors, of chronic obstructive pulmonary disease (COPD) patients who develop chronic hypercapnia (CO₂ retention)?
What topical treatment is recommended for a penile ulcer of two days duration?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.